Opendata, web and dolomites

MINAPATH

MINAPATH: A novel and unique method to diagnose and prevent diseases that are caused by exposure and accumulation of inorganic mineral dusts.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MINAPATH project word cloud

Explore the words cloud of the MINAPATH project. It provides you a very rough idea of what is the project "MINAPATH" about.

industrial    diagnose    exclusion    therapy    life    market    cobalt    silica    category    effort    idiopathic    diagnostic    ageing    mostly    specially    environment    fall    settings    chronic    mineral    expenditure    prepare    diseases    asbestos    maturity    unknown    impacts    globally    healthcare    hazard    quantitative    critical    construction    serving    exposure    minapath    cancer    underlying    workplace    billion    accurate    faces    once    influencing    efficiency    goals    pulmonary    commercial    unsustainable    diagnosis    efficient    qualitative    tests    inflammatory    patient    deteriorating    lung    people    financial    today    prevalence    stay    sustainability    quality    metals    combines    progressing    dusts    undiagnosed    categorized    deposits    coming    minerals    feasibility    fast    slowly    population    relationship    sites    made    finalise    nickel    carcinogenic    risk    occupational    despite    society    cadmium    demonstrating    exposome    carry    2050   

Project "MINAPATH" data sheet

The following table provides information about the project.

Coordinator
MINAPATH DEVELOPPEMENT 

Organization address
address: 56 BD NIELS BOHR CENTRE D ENTREPRISE ET D INNOVATION 2
city: VILLEURBANNE
postcode: 69100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website https://www.minapath.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MINAPATH DEVELOPPEMENT FR (VILLEURBANNE) coordinator 50˙000.00

Map

 Project objective

Today healthcare faces critical challenges coming from an ageing population and the rise of chronic diseases. With a population expected to reach 9 billion people by 2050, healthcare expenditure is at risk of becoming unsustainable. Sustainability requires diagnostic methods to become more efficient, fast and accurate, to facilitate the use of adequate therapy. Despite the effort being made, there are still many diseases that get categorized as idiopathic (unknown cause). Specially in the lung, many inflammatory conditions fall under idiopathic category and stay undiagnosed, while slowly progressing, deteriorating the patient’s quality of life. However, many idiopathic conditions do have a common factor: exposure to mineral dusts such as asbestos, silica or metals (nickel, cadmium & cobalt). We are all at risk of exposure to these minerals, from the environment and workplace, being an occupational hazard in industrial settings and construction sites. Importantly, many of these mineral dusts are carcinogenic, contributing to the increasing prevalence of cancer globally. Despite their impact, today there are no dedicated diagnostic tests to assess mineral exposure, and diagnosis is mostly based on exclusion. In response, we at Minapath have developed a unique method that combines qualitative & quantitative analysis to diagnose the patient’s mineral exposome, serving to identify the underlying cause behind many cases of inflammatory & cancer conditions. After demonstrating the diagnostic relationship between mineral deposits and idiopathic pulmonary diseases, our goal with this project is to finalise the development of our technology and reach market maturity. To achieve these goals, in Phase 1 we aim to carry a Feasibility Study that help us prepare for the main technical, commercial and financial aspects influencing the project. Once completed, our technology will bring significant impacts to society and healthcare, contributing to its efficiency and sustainability.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MINAPATH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MINAPATH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More